Certainly not much emphasis or excitement around the release of their Rett results.
Interesting also that they have only shared a 'reason for delay' following a question put to them.
Surely the necessity for a follow up safety review would be material and require release of information to the market?
and certainly not as eager to bring results to market as Jon is with upcoming Phase II results
Certainly not much emphasis or excitement around the release of...
-
- There are more pages in this discussion • 3,466 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6044 | $15.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 1411 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |